Effect of an Interdisciplinary Spine Rehabilitation Program
Launched by KU LEUVEN · Sep 7, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a rehabilitation program called Revita, designed to help people with chronic low back pain and other spine issues. The goal is to see how effective this program is in improving the health and well-being of patients with these conditions. The research is taking place at University Hospitals Leuven, and they are currently looking for participants who are adults over 18 years old and have been experiencing spine problems for more than six weeks. Eligible participants should also be willing to join the Revita program and understand the process well enough to give informed consent.
If you decide to participate, you can expect to take part in rehabilitation sessions that last about two hours. These sessions will include exercises aimed at improving your spine health. It's important to note that the trial is not open to everyone; for example, individuals who don’t speak Dutch well or cannot participate in the exercises will not be eligible. This study aims to help improve treatment options for patients with long-lasting spine pain, so your involvement could contribute to important findings in this area.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Adults, age \> 18 years
- • Spine problem for \> 6 weeks, needing interdisciplinary care (risk factors, failure of first line treatment, etc)
- • Inclusion in Revita program
- • Informed consent to participate
- • Exclusion criteria
- • Patients without sufficient understanding of the Dutch language
- • Unable to participate in 2h rehabilitation sessions with exercises
About Ku Leuven
KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported